Українська Русский English

ISSN 2522-9028 (Print)
ISSN 2522-9036 (Online)
DOI: https://doi.org/10.15407/fz

Fiziologichnyi Zhurnal

is a scientific journal issued by the

Bogomoletz Institute of Physiology
National Academy of Sciences of Ukraine

Editor-in-chief: V.F. Sagach

The journal was founded in 1955 as
1955 – 1977 "Fiziolohichnyi zhurnal" (ISSN 0015 – 3311)
1978 – 1993 "Fiziologicheskii zhurnal" (ISSN 0201 – 8489)
1994 – 2016 "Fiziolohichnyi zhurnal" (ISSN 0201 – 8489)
2017 – "Fiziolohichnyi zhurnal" (ISSN 2522-9028)

Fiziol. Zh. 2013; 59(3): 10-17


Cardiomyocyte differentiation of individual clones murine induced pluripotent stem cells

Malysheva SV1, Budash HV1, Bil'ko NM1, Heschheller J2

  1. Nаtional University of Kyiv-Mohyla academy, Ukraine
  2. Institute of Neurophisiology, University of Cologne, Germany
DOI: https://doi.org/10.15407/fz59.03.010

Abstract

Cardiomyocyte differentiation of certain clones of murine induced pluripotent stem cells (iPS) was estimated. iPS were obtained due to reprogramming of murine embryonic fibroblasts with transposon-based Sleeping beauty plasmids as sene delivery systems. Differentiation was performed in suspension culture and in attached to tissue-culture plates embryoid bodies (EBs). Ascorbic acid was applied as inductor. According to the obtained results, the differentiation was tenfold more effective in attached EBs. Ascorbic acid stimulated the generation of cardiomiocytes.

Keywords: induced pluripotent stem cells, efficiency of differentiation,cardiomyocytes.

References

  1. Malisheva S.V., Bil'ko N.M., Bil'ko D.I., Sarich T. Diferentsiinii potentsial otrimanih za dopomogoyusistemi transpozoniv indukovanih plyuripotentnihstovburovih klitin mishi . Probl. ekol. ta med. gene-tiki i klin. imunologii. 2012. 4, N 112. P. 37-46.
  2.  
  3. Ada A., Williams C.H., Hao J., Hong C.C. Modifiedmouse embryonic stem cell based assay for quantifyingcardiogenic induction efficiency . J. Vis. Exp. 2011. 50. e2656.
  4.  
  5. Ameen C., R. Strehl, Bjorquist P., Lindahl A., HyllnerSartipy P. Human embryonic stem cells: currenttechnologies and emerging industrial applications . Crit.Rev. Oncol. Hematol. 2008. 65, N 1. P. 54-80. CrossRef PubMed
  6.  
  7. Anversa P., Leri A., Rota M., Hosoda T., Bearzi C.,Urbanek K., Kajstura J., Bolli R. Concise review:stemcells, myocardial regeneration, andmethodologicalartifacts . Stem Cells. 2007. 25, N 3. P. 589-601. CrossRef PubMed
  8.  
  9. Blin G., Nury D., Stefanovic S., Neri T., Guillevic O.,Brinon B., Bellamy V., Rucker-Martin C., Barbry P.,Bel A., Bruneval P., Cowan C., Pouly J., Mitalipov S.,Gouadon E., Binder P., Hagege A., Desnos M., RenaudJ.F., Menasche P., Puceat M. A purified population ofmultipotent cardiovascular progenitors derived fromprimate pluripotent stem cells engrafts in postmyocardialinfarcted nonhuman primates . J. Clin. Invest. 2010. 120, N . 4. P. 1125-1139.
  10.  
  11. Cao N., Liu Z., Chen Z., Wang J., Chen T., Zhao X.,Ma Y., Qin L., Kang J., Wei B., Wang L., Jin Y., YangH.T. Ascorbic acid enhances the cardiac differentiationof induced pluripotent stem cells through promoting theproliferation of cardiac progenitor cells . Cell Res. 2012.22, N 1. P. 219-236.
  12.  
  13. Dimmeler S., Burchfield J., Zeiher A.M. Cell-basedtherapy of myocardial infarction . Arterioscler. Thromb.Vasc. Biol. 2008. 28, N 2. P. 208-216. CrossRef PubMed
  14.  
  15. Fuegemann C.J., Samraj A.K., Walsh S., FleischmannB.K., Jovinge S., Breitbach M. Differentiation of mouseembryonic stem cells into cardiomyocytes via the hangingdropand mass culture methods . Curr. Protoc. Stem. Cell.Biol. 2010. 1, N 1F.11. PubMed
  16.  
  17. Hao J., Sawyer D.B., Hatzopoulos A.K., Hong C.C.Recent progress on chemical biology of pluripotent stemcell self-renewal, reprogramming and cardiomyogenesis. Rec. Pat. Regen. Med. 2011. 1, N 3. P. 263-274. CrossRef PubMed PubMedCentral
  18.  
  19. He J. Q., Ma Y., Lee Y., Thomson J. A., Kamp T. J. Humanembryonic stem cells develop into multiple types of cardiacmyocytes: action potential characterization . Circ. Res. 2003. 93, N 1. P. 32-39. CrossRef PubMed
  20.  
  21. Huu A.L., Prakash S., Shum-Tim D. Cellular cardiomyoplasty:current state of the field . Regen. Med. 2012. 7,N 4. P. 571-582. CrossRef PubMed
  22.  
  23. Kaichi S., Hasegawa K., Takaya T., Yokoo N., Mima T.,Kawamura T., Morimoto T., Ono K., Baba S., Doi H.,S., Nakahata T., Heike T. Cell line-dependentdifferentiation of induced pluripotent stem cells intocardiomyocytes in mice . Cardiovasc. Res. 2010. 88,N 2. P. 314-323. CrossRef PubMed
  24.  
  25. Keller G. Embryonic stem cell differentiation: emergenceof a new era in biology and medicine . Genes Dev. 2005.19, N 10. P. 1129-1155.
  26.  
  27. Kuijk E.W., Chuva de Sousa Lopes S.M., GeijsenN., Macklon N., Roelen B.A. The different shades ofmammalian pluripotent stem cells . Hum. Reprod. Update.2011. 17, N 2. P. 254-271. CrossRef PubMed PubMedCentral
  28.  
  29. Malysheva S., Saric T., Hescheler J., Budash G., BilkoBilko N. Expression of SSEA-1 in different clonesof reprogrammed murine embryonic fibroblasts . Nauk.zapiski NaUKMA: Biologiya ta ekologiya. 2011. N 119. S. 21-25.
  30.  
  31. Meyer T., Sartipy P., F. Blind, Leisgen C., Guenther E.New cell models and assays in cardiac safety profiling. Expert Opin. Drug. Metab. Toxicol. 2007. 3, N 4. P. 507-517. CrossRef PubMed
  32.  
  33. Mochiduki Y., Okita K. Methods for iPS cell generationfor basic research and clinical applications . Biotechnol.J. 2012. 7, N 6. P. 789-797. CrossRef PubMed
  34.  
  35. Murry C.E., Field L.J., Menasch P. Cell-based cardiacrepair reflections at the 10-year point . Circulation. 2005. 112, N 20. P. 3174-3183. CrossRef PubMed
  36.  
  37. Ni T.T., Rellinger E.J., Mukherjee A., Xie S., StephensL., Thorne C.A., Kim K., Hu J., Lee E., Marnett L.,Hatzopoulos A.K., Zhong T.P. Discovering smallmolecules that promote cardiomyocyte generation byWnt signaling . Chem. Biol. 2011. 18, N 12. P. 1658-1668. CrossRef PubMed PubMedCentral
  38.  
  39. Schwappach D.L.B., Boluarte T.A, Suhcke M. Theeconomics of primary prevention of cardiovasculardiseases a systematic review of economic evaluations. Cost. Eff. Resour. Alloc. 2007. 5. P. 1-12
  40.  
  41. So K.H., Han Y.J., Park H.Y., Kim J.G., Sung D.J., BaeY.M., Yang B.C., Park S.B., Chang S.K., Kim E.Y., ParkS.P. Generation of functional cardiomyocytes from mouseinduced pluripotent stem cells . Int. J. Cardiol. 2011. 153, N 3. P. 277-285. CrossRef PubMed
  42.  
  43. Takahashi T., Lord B., Schulze P.C., Fryer R.M., SarangS.S., Gullans S.R., Lee R.T. Ascorbic acid enhancesof embryonic stem cells into cardiacmyocytes . Circulation. 2003. 107, N 14. P. 1912-1916. CrossRef PubMed
  44.  
  45. Xu C., Police S., Rao N., Carpenter M. K. Characterizationand enrichment of cardiomyocytes derived from humanstem cells . Circ. Res. 2002. 91, N 6. P. 501-508. CrossRef PubMed
  46.  
  47. Zhang Q., Major M.B., Takanashi S., Camp N.D., NishiyaN., Peters E.C., Ginsberg M.H., Jian X., Randazzo P.A.,Schultz P.G., Moon R.T., Ding S. Small-molecule synergist of the Wnt/beta-catenin signaling pathway . Proc. Natl. Acad. Sci. USA. 2007. 104, N 18. P. 7444-7448. CrossRef PubMed PubMedCentral
  48.  
  49. Zwi-Dantsis L., Gepstein L. Induced pluripotent stem cells for cardiac repair . Cell Mol. Life Sci. 2012. 69,N 19. P. 3285-3299. CrossRef PubMed
  50.  

© National Academy of Sciences of Ukraine, Bogomoletz Institute of Physiology, 2014-2019.